Managing IP’s statement regarding Talal Abu-Ghazaleh

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Managing IP’s statement regarding Talal Abu-Ghazaleh

ManagingIP_logo_2000px with border.png

Managing IP has been made aware of a television interview in which Talal Abu-Ghazaleh, the founder and chairman of law firm Abu-Ghazaleh Intellectual Property, can be seen making antisemitic comments about the Holocaust. In light of the serious and abhorrent nature of this hate speech, we are taking the following actions:

  • Placing all Managing IP awards won by Abu-Ghazaleh Intellectual Property under review 

  • Removing Abu-Ghazaleh Intellectual Property’s profile and accreditation from our rankings website, ipstars.com 

Our rankings and awards recognise the IP achievements and capabilities of firms and practitioners. Market reputation is one of the key pillars of our evaluation process. As the published comments clearly contravene this ethos, we believe this to be a necessary and justified course of action.

Managing IP has contacted Abu-Ghazaleh Intellectual Property for an official statement. In the meantime, we would like to distance ourselves from antisemitism and hate speech in any form.

more from across site and SHARED ros bottom lb

More from across our site

Julia Bishop is director of IP at Twilio in the US
Hellberg is an IP director at Essity in Sweden
Palińska is the business & IP law lead at CD Projekt Red in Poland
Teemu Itälä is head of legal and compliance for technology standards at Nokia in Finland
Schwitulla is the head of litigation management at Nokia in Germany
David Degen is senior IP counsel at Novartis, Switzerland
Demetrio Roberto Cavicchia is an IP director at Angelini Pharma in Italy
Almeida is the IP group leader at Bosch in Brazil
Amanda Luz is brand protection manager - global at Adidas in the US
Samantak Ghosh is vice president of IP at Avere Therapeutics in the US
Gift this article